Filing Details
- Accession Number:
- 0001209191-21-022949
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-24 21:54:12
- Reporting Period:
- 2021-03-22
- Accepted Time:
- 2021-03-24 21:54:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595893 | Turning Point Therapeutics Inc. | TPTX | Pharmaceutical Preparations (2834) | 463826166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1772399 | Lee Brian Baker | C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 200 San Diego CA 92121 | Svp Of Finance And Admin. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-22 | 1,625 | $0.00 | 4,116 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2021-03-23 | 11,904 | $2.19 | 16,020 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-23 | 1,298 | $3.20 | 17,318 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-23 | 4,545 | $5.12 | 21,863 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-23 | 10,688 | $7.43 | 32,551 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-23 | 4,919 | $97.89 | 27,632 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-23 | 4,459 | $98.76 | 23,173 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-23 | 1,996 | $100.07 | 21,177 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-23 | 5,010 | $100.98 | 16,167 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-23 | 8,061 | $102.23 | 8,106 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-23 | 3,890 | $102.84 | 4,216 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-23 | 100 | $104.17 | 4,116 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-23 | 11,904 | $0.00 | 11,904 | $2.19 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-23 | 1,298 | $0.00 | 1,298 | $3.20 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-23 | 4,545 | $0.00 | 4,545 | $5.12 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-23 | 10,688 | $0.00 | 10,688 | $7.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,165 | 2027-08-08 | No | 4 | M | Direct | |
| 0 | 2028-03-08 | No | 4 | M | Direct | |
| 6,494 | 2028-11-05 | No | 4 | M | Direct | |
| 19,668 | 2029-02-19 | No | 4 | M | Direct |
Footnotes
- Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
- The weighted average sale price for the transaction reported was $97.89, and the range of prices were between $97.34 and $98.315. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $98.76, and the range of prices were between $98.40 and $99.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $100.07, and the range of prices were between $99.56 and $100.56. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $100.98, and the range of prices were between $100.57 and $101.54. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $102.23, and the range of prices were between $101.62 and $102.605. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $102.84, and the range of prices were between $102.64 and $103.21. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- One-fourth of the option vested on July 6, 2018. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.
- Vests in 36 equal successive monthly installments on each monthly anniversary of January 1, 2018.
- 1/48th of the shares vest monthly following November 6, 2018.
- 25% of the shares vest on February 12, 2020 and 1/48th of the shares vest monthly thereafter over the next three years.
Billionaire Hedge Funds
